• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Viatris Inc. - Common Stock (NQ:VTRS)

13.51 -0.29 (-2.10%)
Streaming Delayed Price Updated: 4:00 PM EDT, Mar 13, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 8,966,752
Open 13.89
Bid (Size) 13.33 (200)
Ask (Size) 13.62 (1,400)
Prev. Close 13.80
Today's Range 13.48 - 13.97
52wk Range 6.850 - 16.47
Shares Outstanding 1,212,301,241
Dividend Yield 3.55%
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
This Fund Bet $200 Million on a Biotech Stock Up 50% as Kidney Disease Drug Targets July 7 FDA Decision ↗
March 13, 2026
Vera Therapeutics develops biologic therapies for serious immunological diseases, with a pipeline targeting high-burden conditions. 
Via The Motley Fool
Topics Regulatory Compliance
News headline image
Inside One Fund's $170 Million Bet on a Biotech Stock Up 1,040% in a Year Amid FDA Review for Breast Cancer Drug ↗
March 13, 2026
Celcuity develops targeted cancer therapies and diagnostics, leveraging proprietary technology to advance precision oncology solutions. 
Via The Motley Fool
Topics Regulatory Compliance

Performance

YTD
+8.4%
+8.4%
1 Month
-14.4%
-14.4%
3 Month
+15.9%
+15.9%
6 Month
+40.7%
+40.7%
1 Year
+48.5%
+48.5%

More News

Read More
News headline image
Praxis Stock Has Surged 700% in a Year, and This Fund Is Betting $266 Million on Its Pipeline ↗
March 13, 2026
Via The Motley Fool
Viatris Inc (NASDAQ:VTRS) Beats Q4 2025 Estimates and Completes Strategic Review ↗
February 26, 2026
Via Chartmill
News headline image
Viatris (VTRS): Buy, Sell, or Hold Post Q4 Earnings?
March 10, 2026
Via StockStory
Topics Stocks
News headline image
Viatris (VTRS): From Debt-Laden Merger to Specialty Powerhouse—A 2026 Research Deep Dive
March 03, 2026
Via Finterra
Topics Economy Initial Public Offering Retirement
News headline image
Spotting Winners: Viatris (NASDAQ:VTRS) And Generic Pharmaceuticals Stocks In Q4
March 02, 2026
Via StockStory
Topics Artificial Intelligence Intellectual Property
News headline image
Bastion Bets on Government Spending with $8 Million New Stake in Parsons ↗
February 27, 2026
Via The Motley Fool
News headline image
The Pivot to Growth: Viatris (VTRS) Enters Phase 2 with 2026 Dividend and Capital Allocation Strategy
February 26, 2026
Via Finterra
Topics Economy
Wondering what's happening in today's S&P500 pre-market session? ↗
February 26, 2026
Via Chartmill
News headline image
Viatris (NASDAQ:VTRS) Posts Better-Than-Expected Sales In Q4 CY2025
February 26, 2026
Via StockStory
News headline image
Earnings To Watch: Viatris (VTRS) Reports Q4 Results Tomorrow
February 24, 2026
Via StockStory
Topics World Trade
News headline image
Supreme Court Strikes Down IEEPA Tariffs, Mandating Billions in Immediate Rebates
February 24, 2026
Via MarketMinute
Topics Bonds Economy Government
News headline image
1 Unpopular Stock That Should Get More Attention and 2 Facing Challenges
February 22, 2026
Via StockStory
News headline image
2 Value Stocks Worth Your Attention and 1 We Brush Off
February 16, 2026
Via StockStory
News headline image
Viatris at a Crossroads: Transitioning from Generic Giant to Specialty Powerhouse
February 10, 2026
Via Finterra
Topics Economy World Trade
News headline image
Why Viatris (VTRS) Stock Is Up Today
February 09, 2026
Via StockStory
Uncover the latest developments among S&P500 stocks in today's session. ↗
February 09, 2026
Via Chartmill
Monday's pre-market session: top gainers and losers in the S&P500 index ↗
February 09, 2026
Via Chartmill
News headline image
3 Unprofitable Stocks with Questionable Fundamentals
February 03, 2026
Via StockStory
Topics Electric Vehicles
News headline image
3 Reasons to Sell VTRS and 1 Stock to Buy Instead
January 21, 2026
Via StockStory
News headline image
3 Cash-Producing Stocks with Questionable Fundamentals
January 15, 2026
Via StockStory
What's going on in today's session: S&P500 movers ↗
January 15, 2026
Via Chartmill
Thursday's session: gap up and gap down stock in the S&P500 index ↗
January 15, 2026
Via Chartmill
News headline image
3 Volatile Stocks We Keep Off Our Radar
January 14, 2026
Via StockStory

Frequently Asked Questions

Is Viatris Inc. - Common Stock publicly traded?
Yes, Viatris Inc. - Common Stock is publicly traded.
What exchange does Viatris Inc. - Common Stock trade on?
Viatris Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Viatris Inc. - Common Stock?
The ticker symbol for Viatris Inc. - Common Stock is VTRS on the Nasdaq Stock Market
What is the current price of Viatris Inc. - Common Stock?
The current price of Viatris Inc. - Common Stock is 13.51
When was Viatris Inc. - Common Stock last traded?
The last trade of Viatris Inc. - Common Stock was at 03/13/26 04:00 PM ET
What is the market capitalization of Viatris Inc. - Common Stock?
The market capitalization of Viatris Inc. - Common Stock is 16.38B
How many shares of Viatris Inc. - Common Stock are outstanding?
Viatris Inc. - Common Stock has 16B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap